Characteristics of patients enrolled in studies of the HIV Dementia Scale (HDS) and International HIV Dementia Scale (IHDS).

*Sample sizes refer to the number of patients with data that were useable for meta-analysis, following discussion with study authors as necessary.**Participants were randomly selected from an existing cohort, in proportions approximating published prevalence of MND and HAD.***Participants were sampled to generate two equal groups (n = 50 each): those with symptoms of cognitive impairment and those without. The quoted prevalence of MND and HAD is based on extrapolation up to a larger sample (n = 200) receiving a symptom questionnaire.****The paper reported two independent samples, treated as separate studies in this review.AAN: American Academy of Neurology; ADC: AIDS dementia complex; ART, antiretroviral therapy; HAD: HIV-associated dementia; HDS: HIV dementia scale; IHDS: international HIV dementia scale; IQR: inter-quartile range; MCMD: minor cognitive/motor disorder; MMSE, mini mental state examination; MND: minor neurocognitive disorder; NCI: neurocognitive impairment; SD: standard deviation (numbers refer to number of SD relative to normative means).* 样本量指可用于元分析的有效数据所对应的患者人数，必要时需与研究作者沟通确认。 * 研究对象从现有队列中随机抽取，抽样比例近似于已发表的轻度神经认知障碍（minor neurocognitive disorder, MND）与HIV相关痴呆（HIV-associated dementia, HAD）的患病率。 * 研究对象被分为两组，每组样本量均为50例：分别为存在认知障碍症状者与无认知障碍症状者。 * 本次引用的MND与HAD患病率基于对200例填写症状问卷的更大规模样本的外推结果。 * 该文献报告了两份独立样本，本综述将其视为两项独立研究进行分析。 术语说明： AAN：美国神经病学学会（American Academy of Neurology）； ADC：艾滋病痴呆复合征（AIDS dementia complex）； ART：抗反转录病毒治疗（antiretroviral therapy）； HAD：HIV相关痴呆（HIV-associated dementia）； HDS：HIV痴呆量表（HIV dementia scale）； IHDS：国际HIV痴呆量表（international HIV dementia scale）； IQR：四分位数间距（inter-quartile range）； MCMD：轻度认知/运动障碍（minor cognitive/motor disorder）； MMSE：简易精神状态检查表（mini mental state examination）； MND：轻度神经认知障碍（minor neurocognitive disorder）； NCI：神经认知损害（neurocognitive impairment）； SD：标准差（standard deviation，文中数值指相对于常模均值的标准差倍数）